Table S1.

Relative importance of different treatment attributes in defined RRMM patient

Attributes	Relative importance, expressed in % for “Gender”		Relative importance, expressed in % for “Age”		Relative importance, expressed in % for “Disease duration”		Relative importance, expressed in % for “Distance to treating physician”
	Male (n=53)	Female (n=31)	≤63.5 years (n=42)	>63.5 years (n=42)	≤4.18 years (n=42)	>4.18 years (n=42)	≤15 km (n=45)	>15 km (n=39)
Therapy regimen/drug administration	39.20**	39.25**	37.66**	40.07**	38.43**	39.32**	35.44**	42.41**
Time without progression of disease	35.55**	43.20**	42.32**	35.21**	39.75**	37.38*	38.73**	38.95**
Possibility of side effects affecting the blood	8.38*	8.47*	4.64	12.00*	6.78#	10.60*	10.04*	7.04#
Possibility of side effect heart failure	16.86**	9.08**	15.37**	12.73**	15.04**	12.70**	15.79**	11.59**
Decision	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Notes: Significance levels:

^**P<0.001;

^*P<0.05;

^#P<0.10 (significance of the respective attribute within the conditional logit model). This table gives an overview of the importance of treatment attributes for different patient. Separate conditional logit regression models were estimated for each of the presented subgroups. Threshold: median.

Abbreviation: RRMM, relapsed refractory multiple myeloma.